Foundayo

FDA-Approved Weight Loss Pill: Cuban Directory’s Breakthrough

by

FDA Approves Foundayo: A New Oral Weight Loss Option Emerges In a significant development for obesity treatment, the Food and Drug Administration (FDA) has granted approval to Foundayo, an oral formulation of the GLP-1 receptor agonist, semaglutide. This marks a pivotal moment, offering a convenient alternative to injectable weight loss medications and sparking considerable interest … Read more

Lilly’s GLP-1 Pill Approved: Novo Nordisk Rival

by

Eli Lilly’s Foundayo Receives FDA Approval, Intensifying Competition in Weight Loss Medications In a significant development for individuals managing obesity and related health conditions, the Food and Drug Administration (FDA) has granted approval to Eli Lilly’s Foundayo (orforglipron), an oral glucagon-like peptide-1 (GLP-1) receptor agonist. This approval arrives approximately three months after Novo Nordisk introduced … Read more

© 2026 Archyworldys. All rights reserved.

For contact, advertising, copyright, issues email: [email protected]